SCHEMBL753308

SCHEMBL753308

CC(C)C(=O)OC1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.53
EPHX1 P07099 2/20 0.47
NAAA Q02083 2/20 0.43
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CYP2C19 P33261 2/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
GAA P10253 1/20 0.38
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2419961 0.98 CYP19A1 (0.50) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL7915891 0.93 CYP19A1 (0.46) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL754296 0.88
SCHEMBL8984845 0.86 CYP19A1 (0.53) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL23323307 0.86 CYP19A1 (0.46) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL4675856 0.84 CYP19A1 (0.51) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL22511301 0.84 SERPINE1 (0.41) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL531407 0.84 CYP19A1 (0.51) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL31697559 0.84 CYP19A1 (0.51) CYP19A1EPHX1NAAAHTTL3MBTL1
SCHEMBL12611092 0.83 CYP19A1 (0.41) CYP19A1EPHX1NAAAHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4206184-A1 PHENOL DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-07-05 EP claimed
US-11459315-B2 Modulators of methyl modifying enzymes, compositions and uses thereof CONSTELLATION PHARMACEUTICALS, INC. (US) 2022-10-04 US claimed
CN-109608939-B Quantum dot ink and quantum dot color film 苏州星烁纳米科技有限公司 2022-02-01 CN claimed
CN-109164686-B Positive photoresist stripping and cleaning composition and application thereof 江阴江化微电子材料股份有限公司 2022-01-28 CN claimed
CN-108914564-B Preparation method of moisture-absorbing, breathable and antibacterial spunlace non-woven fabric for polyurethane synthetic leather 山东旭辉无纺布制品有限公司 2021-05-04 CN claimed
CN-107759473-A A kind of green synthesis method of allyl cyclohexyl propionate 江苏馨瑞香料有限公司 2018-03-06 CN claimed
US-9427777-B2 Process for producing charge retention medium ASAHI GLASS COMPANY, LIMITED (JP) 2016-08-30 US claimed
CN-1276794-C Reactivation method of supported palladium catalyst CHINA PETROLEUM & CHEMICAL (CN) 2006-09-27 CN claimed
CN-1261223-C Method for regenerating palladium catalyst CHINA PETROLEUM & CHEMICAL (CN) 2006-06-28 CN claimed
EP-1558654-A4 NOVEL COPOLYMER, PHOTORESIST COMPOSITIONS THEREOF AND DEEP UV BILAYER SYSTEM THEREOF FUJIFILM ELECTRONIC MATERIALS (US) 2006-04-05 EP claimed
EP-1558654-A2 NOVEL COPOLYMER, PHOTORESIST COMPOSITIONS THEREOF AND DEEP UV BILAYER SYSTEM THEREOF Fujifilm Electronic Materials USA, Inc. (US) 2005-08-03 EP claimed
US-6916543-B2 Copolymer, photoresist compositions thereof and deep UV bilayer system thereof ARCH SPECIALTY CHEMICALS, INC. (US) 2005-07-12 US claimed
CN-1541769-A Method for regenerating palladium catalyst 中国石油化工股份有限公司 2004-11-03 CN claimed
CN-1541767-A Reactivation method of supported palladium catalyst 中国石油化工股份有限公司 2004-11-03 CN claimed
US-20040137362-A1 Novel copolymer, photoresist compositions thereof and deep UV bilayer system thereof ARCH SPECIALTY CHEMICALS, INC. 2004-07-15 US claimed
WO-2004040371-A2 NOVEL COPOLYMER AND PHOTORESIST COMPOSITIONS THEREOF ARCH SPECIALTY CHEMICALS, INC. (US) 2004-05-13 WO claimed
CN-1136975-C Method for resisting carbon monoxide poisoning of noble metal catalyst 中国石油化工股份有限公司 2004-02-04 CN claimed
CN-1344585-A Method for resisting carbon monoxide poisoning of noble metal catalyst CHINESE PETROCHEMICAL CO LTD (CN) 2002-04-17 CN claimed
CN-85102572-A Utilize 4 vinyl cyclohexene to synthesize allyl cyclohexyl propionate 1986-07-30 CN claimed
EP-4232518-B1 COMPOSITION SAMSUNG ELECTRONICS CO LTD (KR) 2026-02-18 EP disclosed
EP-4225858-B1 COMPOSITION SAMSUNG ELECTRONICS CO LTD (KR) 2025-12-03 EP disclosed
EP-4001257-B1 METHOD FOR PRODUCING ALPHA-ACYLOXY CARBOXYLIC ACID ESTER MITSUBISHI GAS CHEMICAL CO (JP) 2025-11-19 EP disclosed
US-12378181-B2 Method for producing alpha-acyloxycarboxylic acid ester MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-08-05 US disclosed
US-20240067657-A1 AMIDO-SUBSTITUTED PYRIDYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES MERCK SHARP & DOHME LLC (US) 2024-02-29 US disclosed
EP-4318629-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODES, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICES, AND SECONDARY BATTERY AGC INC. (JP) 2024-02-07 EP disclosed
CN-117440986-A Polyisobutene having a high content of specific double bond isomers 巴斯夫欧洲公司 2024-01-23 CN disclosed
CN-115090283-B Supported core-shell catalyst, preparation method thereof and application thereof in catalyzing cyclopentyl butyrolactone hydrogenation 浙江新化化工股份有限公司 2024-01-02 CN disclosed
US-20230420686-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODE, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICE, AND SECONDARY BATTERY AGC Inc. (JP) 2023-12-28 US disclosed
US-20230382940-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-11-30 US disclosed
US-20230382940-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-11-30 US disclosed
CN-117043978-A Primer for electrode of electric storage device, primer-forming composition, electrode for electric storage device, and secondary battery AGC株式会社 2023-11-10 CN disclosed
CN-112119149-B Cleaning composition 奇华顿股份有限公司 2023-10-13 CN disclosed
EP-3013340-B9 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN PHARMACEUTICALS INC (US) 2023-10-04 EP disclosed
CN-116836141-A New bevacizidine intermediate, preparation method thereof and method for synthesizing bevacizidine by using same 上海绿智创领医药科技有限公司 2023-10-03 CN disclosed
WO-2023176458-A1 DISINFECTING COMPOSITION CONTAINING THIAZOLE CARBOXYLIC ACID HYDRAZIDE COMPOUND 石原産業株式会社 2023-09-21 WO disclosed
US-11739047-B2 Alpha-truxillic acid derivatives and pharmaceutical compositions thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-08-29 US disclosed
EP-4206184-A1 PHENOL DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-07-05 EP disclosed
CN-113683629-B Substituted heteroaryl compounds, compositions and uses thereof 北京范恩柯尔生物科技有限公司 2023-07-04 CN disclosed
EP-3013340-B1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN BIOPHARMA INC (US) 2023-06-07 EP disclosed
CN-116075531-A Process for preparing highly reactive isobutylene homo-or copolymers 巴斯夫欧洲公司 2023-05-05 CN disclosed
US-11639337-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof XWPharma Ltd. (KY) 2023-05-02 US disclosed
US-11639337-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof XWPharma Ltd. (KY) 2023-05-02 US disclosed
CN-116023553-A Catalyst for olefin polymerization reaction, catalyst system and application 中国石油化工股份有限公司 2023-04-28 CN disclosed
CN-116023554-A Catalyst active component, solid catalyst and catalyst system for olefin polymerization 中国石油化工股份有限公司 2023-04-28 CN disclosed
US-20230040586-A1 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF GILEAD SCIENCES, INC. 2023-02-09 US disclosed
CN-112553891-B Preparation method of moisture-absorbing, breathable and antibacterial spunlace non-woven fabric for polyurethane synthetic leather 杭州安加空间新材料科技有限公司 2022-12-09 CN disclosed
CN-112637973-B Long-life ceramic electric heater 蚌埠市科达电器有限公司 2022-10-11 CN disclosed
CN-115090283-A Supported core-shell catalyst, preparation method thereof and application thereof in catalyzing hydrogenation of cyclopentyl butyrolactone 浙江新化化工股份有限公司 2022-09-23 CN disclosed
US-20220274909-A1 METHOD FOR PRODUCING ALPHA-ACYLOXYCARBOXYLIC ACID ESTER MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-09-01 US disclosed
US-11407732-B1 Tricyclic degraders of Ikaros and Aiolos C4 THERAPEUTICS, INC. (US) 2022-08-09 US disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
EP-4001257-A1 METHOD FOR PRODUCING A-ACYLOXY CARBOXYLIC ACID ESTER MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-05-25 EP disclosed
CN-112594296-B High-performance permanent magnet bistable electromagnetic clutch 蚌埠市科达电器有限公司 2022-04-01 CN disclosed
CN-114127042-A Process for producing alpha-acyloxycarboxylic acid ester 三菱瓦斯化学株式会社 2022-03-01 CN disclosed
CN-109439067-B Quantum dot ink and quantum dot color film 苏州星烁纳米科技有限公司 2022-02-22 CN disclosed
CN-109608939-B Quantum dot ink and quantum dot color film 苏州星烁纳米科技有限公司 2022-02-01 CN disclosed
CN-109164686-B Positive photoresist stripping and cleaning composition and application thereof 江阴江化微电子材料股份有限公司 2022-01-28 CN disclosed
CN-109535836-B Quantum dot ink and quantum dot color film 苏州星烁纳米科技有限公司 2021-12-31 CN disclosed
CN-113683629-A Substituted heteroaryl compounds, compositions and uses thereof 北京范恩柯尔生物科技有限公司 2021-11-23 CN disclosed
CN-110172274-B Quantum dot ink and electroluminescent device 苏州星烁纳米科技有限公司 2021-11-19 CN disclosed
CN-113646417-A Perfumed compositions 奇华顿股份有限公司 2021-11-12 CN disclosed
US-11028058-B2 Heterocyclic compounds as adenosine antagonists NUVATION BIO INC. (US) 2021-06-08 US disclosed
CN-108914564-B Preparation method of moisture-absorbing, breathable and antibacterial spunlace non-woven fabric for polyurethane synthetic leather 山东旭辉无纺布制品有限公司 2021-05-04 CN disclosed
CN-112637973-A Long-life ceramic electric heater 蚌埠市科达电器有限公司 2021-04-09 CN disclosed
US-10968163-B2 Alpha-truxillic acid derivatives and pharmaceutical compositions thereof THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2021-04-06 US disclosed
CN-112594296-A High-performance permanent magnet bistable electromagnetic clutch 蚌埠市科达电器有限公司 2021-04-02 CN disclosed
CN-112553891-A Preparation method of moisture-absorbing, breathable and antibacterial spunlace non-woven fabric for polyurethane synthetic leather 段小宁 2021-03-26 CN disclosed
WO-2021014988-A1 METHOD FOR PRODUCING α-ACYLOXY CARBOXYLIC ACID ESTER 三菱瓦斯化学株式会社 2021-01-28 WO disclosed
CN-106715374-B Polyether diol and process for producing the same 三菱瓦斯化学株式会社 2021-01-12 CN disclosed
US-10882832-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof XW LABORATORIES INC. (KY) 2021-01-05 US disclosed
CN-112119149-A Detergent composition 奇华顿股份有限公司 2020-12-22 CN disclosed
WO-2020201258-A1 FRAGRANCED COMPOSITION GIVAUDAN SA (CH) 2020-10-08 WO disclosed
US-20200181102-A1 BICYCLIC HETEROARYL DERIVATIVES AND PREPARATION AND USES THEREOF XWPharma Ltd. (KY) 2020-06-11 US disclosed
CN-111116576-A Quinolizinone compound and preparation method thereof 北京师范大学 2020-05-08 CN disclosed
US-10640476-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof XW LABORATORIES INC. (KY) 2020-05-05 US disclosed
CN-110776945-A Method for treating oxidized tail gas in hydrogen peroxide production 安徽金禾实业股份有限公司 2020-02-11 CN disclosed
CN-110697658-A Water washing method for producing hydrogen peroxide by anthraquinone process 安徽金禾实业股份有限公司 2020-01-17 CN disclosed
WO-2019215074-A1 WASHING COMPOSITION GIVAUDAN SA (CH) 2019-11-14 WO disclosed
US-10450301-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2019-10-22 US disclosed
CN-107210377-B Varnish for forming charge-transporting thin film 日产化学工业株式会社 2019-07-05 CN disclosed
US-20190055190-A1 PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO NEUBASE THERAPEUTICS, INC. 2019-02-21 US disclosed
US-10202378-B2 Therapeutic compounds and uses thereof GENENTECH, INC. (US) 2019-02-12 US disclosed
US-20190023666-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT (CA) 2019-01-24 US disclosed
CN-109071693-A Resin combination is used in the formation of high refractive index cured film 日产化学株式会社 2018-12-21 CN disclosed
US-20180155384-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA, INC. 2018-06-07 US disclosed
EP-2655392-B1 CYCLIC NUCLEOTIDE ANALOGS ALIOS BIOPHARMA INC (US) 2018-04-18 EP disclosed
US-9918473-B2 Use of aryl carbamates in agriculture and other plant-related areas North Carolian State University (US) 2018-03-20 US disclosed
CN-107759473-A A kind of green synthesis method of allyl cyclohexyl propionate 江苏馨瑞香料有限公司 2018-03-06 CN disclosed
US-20180009805-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2018-01-11 US disclosed
CN-107540797-A Non-conductive cohesive film composition and the non-conductive adhesive film for including it 利诺士尖端材料有限公司 2018-01-05 CN disclosed
CN-105209416-B Polyol ether compound and process for producing the same 三菱瓦斯化学株式会社 2017-12-08 CN disclosed
CN-104884418-B Polyether diol and process for producing the same 三菱瓦斯化学株式会社 2017-12-01 CN disclosed
US-9810981-B2 Pattern formation method, etching method, electronic device manufacturing method, and electronic device FUJIFILM CORPORATION (JP) 2017-11-07 US disclosed
US-9770439-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-26 US disclosed
US-9770439-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-09-26 US disclosed
CN-107210378-A Charge-transporting varnish, charge-transporting film and organic electroluminescent device 日产化学工业株式会社 2017-09-26 CN disclosed
CN-107210377-A Varnish for forming charge-transporting thin film 日产化学工业株式会社 2017-09-26 CN disclosed
US-9760005-B2 Salt, acid generator, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
CN-107109103-A Resin composition for forming cured film, conductive member, and method for inhibiting corrosion of metal electrode and/or metal wiring 日产化学工业株式会社 2017-08-29 CN disclosed
US-20170196848-A1 Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives ALKERMES PHARMA IRELAND LTD (IE) 2017-07-13 US disclosed
CN-106715374-A Polyether diol and process for producing the same 三菱瓦斯化学株式会社 2017-05-24 CN disclosed
US-9599897-B2 Salt, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-03-21 US disclosed
US-9585965-B2 Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives ALKERMES PHARMA IRELAND LIMITED (IE) 2017-03-07 US disclosed
US-9585965-B2 Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives ALKERMES PHARMA IRELAND LIMITED (IE) 2017-03-07 US disclosed
US-20170037075-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen Biopharma, Inc. 2017-02-09 US disclosed
US-20170002037-A1 CYCLIC NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. 2017-01-05 US disclosed
US-20160353739-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS UNIV NORTH CAROLINA STATE (US) 2016-12-08 US disclosed
US-9439436-B2 Use of aryl carbamates in agriculture and other plant-related areas NORTH CAROLINA STATE UNIVERSITY (US) 2016-09-13 US disclosed
US-9427777-B2 Process for producing charge retention medium ASAHI GLASS COMPANY, LIMITED (JP) 2016-08-30 US disclosed
CN-103402975-B beta-hydroxyalkylamide and resin composition 东洋油墨SC控股株式会社 2016-08-17 CN disclosed
US-20160199355-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL MAYERS SQUIBB COMPANY (US) 2016-07-14 US disclosed
US-9365605-B2 Cyclic nucleotide analogs ALIOS BIOPHARMA, INC. (US) 2016-06-14 US disclosed
US-20160158200-A1 Combinations of Hepatitis C Virus Inhibitors BRISTOL MYERS SQUIBB CO (US) 2016-06-09 US disclosed
CN-103222021-B Charge retention medium ASAHI GLASS CO.,LTD. (JP) 2016-05-11 CN disclosed
US-9326973-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-05-03 US disclosed
US-9278990-B2 Substituted nucleotide analogs ALIOS BIOPHARMA, INC. (US) 2016-03-08 US disclosed
US-20160062233-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-03 US disclosed
US-20160052877-A1 SALT, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-02-25 US disclosed
US-9199996-B2 Pyrido[4,3-B]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2015-12-01 US disclosed
US-20150327552-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS UNIV NORTH CAROLINA STATE (US) 2015-11-19 US disclosed
US-20150320875-A1 Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives ALKERMES PHARMA IRELAND LTD (IE) 2015-11-12 US disclosed
US-20150315146-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYLETHYNYL)-BICYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-11-05 US disclosed
US-20150315146-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYLETHYNYL)-BICYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-11-05 US disclosed
US-20150305334-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-10-29 US disclosed
US-20150305334-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2015-10-29 US disclosed
US-20150297568-A1 Hepatitis C Virus Inhibitors BRISTOL MYERS SQUIBB CO (US) 2015-10-22 US disclosed
EP-2450406-B1 FLUORINE-CONTAINING COPOLYMER COMPOSITION AND METHOD FOR PRODUCING SAME ASAHI GLASS CO LTD (JP) 2015-10-14 EP disclosed
CN-104945309-A Novel nitroso compounds as nitroxyl donors and methods of use thereof CARDIOXYL PHARMACEUTICALS INC 2015-09-30 CN disclosed
US-9125408-B2 Use of aryl carbamates in agriculture and other plant-related areas NORTH CAROLINA STATE UNIVERSITY (US) 2015-09-08 US disclosed
US-9072788-B2 Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives ALKERMES PHARMA IRELAND LIMITED (IE) 2015-07-07 US disclosed
CN-102076342-B Novel nitroso compounds as nitroxyl donors and methods of use thereof CARDIOXYL PHARMACEUTICALS INC 2015-06-10 CN disclosed
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US disclosed
US-20150038451-A1 SUBSTITUTED NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. 2015-02-05 US disclosed
US-8940688-B2 Fluorinated tripeptide HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-01-27 US disclosed
US-8940688-B2 Fluorinated tripeptide HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-01-27 US disclosed
US-20150023913-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2015-01-22 US disclosed
US-8884022-B2 Inhibition of bacterial biofilms with aryl carbamates NORTH CAROLINA STATE UNIVERSITY (US) 2014-11-11 US disclosed
US-8859561-B2 Pyrido[4,3-b]indoles and methods of use MEDIVATION TECHNOLOGIES, INC. (US) 2014-10-14 US disclosed
US-8809264-B2 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2014-08-19 US disclosed
US-8664423-B2 Process for the preparation of acylated secondary alcohol alkoxylates and secondary alcohol alkoxylates SHELL OIL COMPANY (US) 2014-03-04 US disclosed
EP-2648197-A1 METHOD FOR PRODUCING CHARGE RETENTION MEDIUM Asahi Glass Company, Limited (JP) 2013-10-09 EP disclosed
EP-2648196-A1 CHARGE RETENTION MEDIUM Asahi Glass Company, Limited (JP) 2013-10-09 EP disclosed
US-20130261248-A1 CHARGE RETENTION MEDIUM ASAHI GLASS COMPANY, LIMITED (JP) 2013-10-03 US disclosed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US disclosed
US-20130202810-A1 PROCESS FOR PRODUCING CHARGE RETENTION MEDIUM ASAHI GLASS COMPANY, LIMITED (JP) 2013-08-08 US disclosed
US-20130190344-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE MEDIVATION TECHNOLOGIES, INC. (US) 2013-07-25 US disclosed
CN-103222021-A Charge retention medium ASAHI GLASS CO LTD 2013-07-24 CN disclosed
US-20130183269-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-07-18 US disclosed
US-20130172187-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS NORTH CAROLINA STATE UNIVERSITY 2013-07-04 US disclosed
US-20130123225-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES NORTH CAROLINA STATE UNIVERSITY 2013-05-16 US disclosed
US-20130053493-A1 METHOD FOR PRODUCING FLUORINATED COPOLYMER COMPOSITION, COATING COMPOSITION, ARTICLE HAVING COATING FILM, AND MOLDED PRODUCT ASAHI GLASS COMPANY, LIMITED (JP) 2013-02-28 US disclosed
EP-2559742-A1 COATING COMPOSITION AND PRODUCTION METHOD FOR SAME, AND FORMATION METHOD FOR COATING FILM USING SAME Asahi Glass Company, Limited (JP) 2013-02-20 EP disclosed
US-20130037103-A1 BACK SHEET FOR SOLAR CELL MODULE AND SOLAR CELL MODULE ASAHI GLASS COMPANY, LIMITED (JP) 2013-02-14 US disclosed
US-8361958-B2 Oximyl HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2013-01-29 US disclosed
US-8361958-B2 Oximyl HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2013-01-29 US disclosed
US-20130017334-A1 COATING COMPOSITION AND PROCESS FOR ITS PRODUCTION, AND PROCESS FOR FORMING COATING FILM BY USING THE COMPOSITION ASAHI GLASS COMPANY, LIMITED (JP) 2013-01-17 US disclosed
CN-102844884-A Back sheet for solar cell module and solar cell module ASAHI GLASS CO LTD 2012-12-26 CN disclosed
EP-2181763-B1 Catalyst and process for alkoxylation SHELL INT RESEARCH (NL) 2012-06-20 EP disclosed
EP-2450406-A1 FLUORINE-CONTAINING COPOLYMER COMPOSITION AND METHOD FOR PRODUCING SAME Asahi Glass Company, Limited (JP) 2012-05-09 EP disclosed
CN-101450308-B Carbon-supported noble metal catalyst and preparation method thereof CHINA PETROLEUM & CHEMICAL 2012-05-09 CN disclosed
US-20120108723-A1 FLUOROCOPOLYMER COMPOSITION AND ITS PRODUCTION PROCESS ASAHI GLASS COMPANY, LIMITED (JP) 2012-05-03 US disclosed
WO-2012040126-A1 SUBSTITUTED NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2012-03-29 WO disclosed
WO-2012040127-A1 SUBSTITUTED NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2012-03-29 WO disclosed
US-8138215-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-20 US disclosed
US-8101567-B2 Heteroaryl-containing tripeptide HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2012-01-24 US disclosed
US-8101567-B2 Heteroaryl-containing tripeptide HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2012-01-24 US disclosed
US-20110319422-A1 PRODRUGS OF NH-ACIDIC COMPOUNDS: ESTER, CARBONATE, CARBAMATE AND PHOSPHONATE DERIVATIVES ALKERMES, INC. (US) 2011-12-29 US disclosed
US-20110245272-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE MEDIVATION TECHNOLOGIES, INC. 2011-10-06 US disclosed
US-20110242654-A1 Hardcoat layer-forming composition, optical film, production method of optical film, polarizing plate and image display device FUJIFILM CORPORATION (JP) 2011-10-06 US disclosed
US-20110237817-A1 PROCESS FOR THE PREPARATION OF ACYLATED SECONDARY ALCOHOL ALKOXYLATES AND SECONDARY ALCOHOL ALKOXYLATES SHELL OIL COMPANY 2011-09-29 US disclosed
EP-2349974-A1 PROCESS FOR THE PREPARATION OF ACYLATED SECONDARY ALCOHOL ALKOXYLATES AND SECONDARY ALCOHOL ALKOXYLATES Shell Internationale Research Maatschappij B.V. (NL) 2011-08-03 EP disclosed
CN-102076342-A Novel nitroso compounds as nitroxyl donors and methods of use thereof CARDIOXYL PHARMACEUTICALS INC 2011-05-25 CN disclosed
CN-101041618-B New production technique of cyclohexyl allyl propionate HANGZHOU AROMA CHEMICAL COMPANY 2011-05-25 CN disclosed
US-20110091812-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-04-21 US disclosed
US-20110091812-A1 PATTERNING PROCESS AND RESIST COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-04-21 US disclosed
US-7872716-B2 Optical compensation film, polarizing plate and liquid crystal display FUJIFILM CORPORATION (JP) 2011-01-18 US disclosed
US-20100303755-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2010-12-02 US disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
US-7728148-B2 Acyclic oximyl hepatitis C protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
US-7728148-B2 Acyclic oximyl hepatitis C protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2010-06-01 US disclosed
WO-2010049465-A1 PROCESS FOR THE PREPARATION OF ACYLATED SECONDARY ALCOHOL ALKOXYLATES AND SECONDARY ALCOHOL ALKOXYLATES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2010-05-06 WO disclosed
EP-2181763-A1 Catalyst and process for alkoxylation Shell Internationale Research Maatschappij B.V. (NL) 2010-05-05 EP disclosed
US-7658864-B2 Liquid crystal composition, optical compensation film and liquid crystal display device FUJIFILM CORPORATION (JP) 2010-02-09 US disclosed
US-7635683-B2 Quinoxalinyl tripeptide hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2009-12-22 US disclosed
US-7635683-B2 Quinoxalinyl tripeptide hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2009-12-22 US disclosed
US-7635697-B2 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases SCHERING CORPORATION (US) 2009-12-22 US disclosed
US-20090232868-A1 Nitric Oxide Releasing Polymer Composition MEDTRONIC VASCULAR, INC. (US) 2009-09-17 US disclosed
US-20090202485-A1 HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-08-13 US disclosed
US-20090197888-A1 FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-08-06 US disclosed
US-20090197888-A1 FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-08-06 US disclosed
WO-2009094438-A1 HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-07-30 WO disclosed
WO-2009076166-A2 OXIMYL HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-18 WO disclosed
US-20090155210-A1 OXIMYL HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-06-18 US disclosed
US-20090155210-A1 OXIMYL HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-06-18 US disclosed
WO-2009076173-A2 FLUORINATED TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-18 WO disclosed
CN-101450308-A Carbon-supported noble metal catalyst and preparation method thereof CHINA PETROCHEMICAL CO LTD (CN) 2009-06-10 CN disclosed
US-20090130059-A1 TETRAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-05-21 US disclosed
US-20090010958-A1 Compositions effective in altering the perception of malodor PATUS LTD. (IL) 2009-01-08 US disclosed
US-20090009693-A1 Liquid Crystal Composition, Optical Compensation Film and Liquid Crystal Display Device FUJIFILM CORPORATION (JP) 2009-01-08 US disclosed
US-20090012324-A1 Process for Production of Carboxylic Acid Ester or Ether Compound NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2009-01-08 US disclosed
US-20090005387-A1 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2009-01-01 US disclosed
EP-1095935-B1 6-Hydroxy-5,6-dihydrouracils as herbicides SUMITOMO CHEMICAL CO (JP) 2008-12-17 EP disclosed
US-7449447-B2 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2008-11-11 US disclosed
US-20080221003-A1 CONSUMER PRODUCTS HAVING VARYING ODOR PATTERNS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-09-11 US disclosed
US-20080207481-A1 CONSUMER PRODUCTS HAVING VARYING ODORS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-08-28 US disclosed
US-20080207476-A1 PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCE PROPERTIES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-08-28 US disclosed
US-20080199805-A1 PHOTOSENSITIVE COMPOSITIONS EMPLOYING SILICON-CONTAINING ADDITIVES FUJIFILM ELECTRONIC MATERIALS. U.S.A., INC. 2008-08-21 US disclosed
US-20080192191-A1 Optical Compensation Film, Polarizing Plate and Liquid Crystal Display FUJIFILM CORPORATION (JP) 2008-08-14 US disclosed
WO-2008098189-A1 PHOTOSENSITIVE COMPOSITIONS EMPLOYING SILICON-CONTAINING ADDITIVES FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2008-08-14 WO disclosed
US-20080187516-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-08-07 US disclosed
US-20080187516-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-08-07 US disclosed
US-20080125444-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-05-29 US disclosed
US-20080125444-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-05-29 US disclosed
CN-100384813-C Process for preparing nateglinide and intermediates thereof TEVA PHARMA (IL) 2008-04-30 CN disclosed
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 US disclosed
US-20080032936-A1 Quinoxalinyl tripeptide hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2008-02-07 US disclosed
US-20080032936-A1 Quinoxalinyl tripeptide hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2008-02-07 US disclosed
US-20080008681-A1 MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-01-10 US disclosed
US-20080008681-A1 MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. 2008-01-10 US disclosed
WO-2008002924-A2 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-01-03 WO disclosed
US-20070299078-A1 Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors ENANTA PHARMACEUTICALS, INC. 2007-12-27 US disclosed
WO-2007146695-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2007-12-21 WO disclosed
WO-2007113650-A2 A NOVEL AND IMPROVED PROCESS FRO THE PREPARATION OF NATEGLINIDE AND ITS POLYMORPH FORM-H CADILA PHARMACEUTICALS LIMITED (IN) 2007-10-11 WO disclosed
CN-101041618-A New production technique of cyclohexyl allyl propionate HANGZHOU AROMA CHEMICAL COMPAN (CN) 2007-09-26 CN disclosed
CN-100337753-C Method for regenerating catalyst by supercritical fluid CHINA PETROLEUM & CHEMICAL (CN) 2007-09-19 CN disclosed
EP-1781239-A2 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR Patus Ltd (IL) 2007-05-09 EP disclosed
US-20070065394-A1 Compositions effective in altering the perception of malodor PATUS LTD. (IL) 2007-03-22 US disclosed
US-20070002232-A1 Optical compensation film, polarizing plate and liquid crystal display device FUJI PHOTO FILM CO., LTD. (JP) 2007-01-04 US disclosed
CN-1276794-C Reactivation method of supported palladium catalyst CHINA PETROLEUM & CHEMICAL (CN) 2006-09-27 CN disclosed
CN-1267188-C Method for resisting carbon monoxide poisoning of palladium catalyst CHINA PETROLEUM & CHEMICAL (CN) 2006-08-02 CN disclosed
CN-1261223-C Method for regenerating palladium catalyst CHINA PETROLEUM & CHEMICAL (CN) 2006-06-28 CN disclosed
CN-1762600-A Method for regenerating catalyst by supercritical fluid CHINA PETROLEUM & CHEMICAL (CN) 2006-04-26 CN disclosed
EP-1558654-A4 NOVEL COPOLYMER, PHOTORESIST COMPOSITIONS THEREOF AND DEEP UV BILAYER SYSTEM THEREOF FUJIFILM ELECTRONIC MATERIALS (US) 2006-04-05 EP disclosed
WO-2005046632-A9 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR PATUS LTD (IL) 2005-09-22 WO disclosed
CN-1671649-A Process for preparing nateglinide and intermediates thereof TEVA PHARMA (IL) 2005-09-21 CN disclosed
EP-1101761-B1 Process for producing 3-phenyluracil compounds SUMITOMO CHEMICAL CO (JP) 2005-08-17 EP disclosed
EP-1558654-A2 NOVEL COPOLYMER, PHOTORESIST COMPOSITIONS THEREOF AND DEEP UV BILAYER SYSTEM THEREOF Fujifilm Electronic Materials USA, Inc. (US) 2005-08-03 EP disclosed
US-6916543-B2 Copolymer, photoresist compositions thereof and deep UV bilayer system thereof ARCH SPECIALTY CHEMICALS, INC. (US) 2005-07-12 US disclosed
WO-2005046632-A2 COMPOSITIONS EFFECTIVE IN ALTERING THE PERCEPTION OF MALODOR PATUS LTD. (IL) 2005-05-26 WO disclosed
CN-1541762-A Method for resisting carbon monoxide poisoning of palladium catalyst 中国石油化工股份有限公司 2004-11-03 CN disclosed
CN-1541767-A Reactivation method of supported palladium catalyst 中国石油化工股份有限公司 2004-11-03 CN disclosed
CN-1541769-A Method for regenerating palladium catalyst 中国石油化工股份有限公司 2004-11-03 CN disclosed
US-20040137362-A1 Novel copolymer, photoresist compositions thereof and deep UV bilayer system thereof ARCH SPECIALTY CHEMICALS, INC. 2004-07-15 US disclosed
WO-2004040371-A2 NOVEL COPOLYMER AND PHOTORESIST COMPOSITIONS THEREOF ARCH SPECIALTY CHEMICALS, INC. (US) 2004-05-13 WO disclosed
WO-2004018408-A1 SYNTHESIS AND PURIFICATION OF NATEGLINIDE GLENMARK PHARMACEUTICALS LIMITED (US) 2004-03-04 WO disclosed
CN-1136975-C Method for resisting carbon monoxide poisoning of noble metal catalyst 中国石油化工股份有限公司 2004-02-04 CN disclosed
US-6667285-B1 Branched-chain carboxylic acid monoalkyl ester with outstanding hydrolytic stability NEW JAPAN CHEMICAL CO., LTD. (JP) 2003-12-23 US disclosed
US-20030216258-A1 Condensed heterocylic compounds and herbicides containing them as active ingredients SUMITOMO CHEMICAL COMPANY, LIMITED 2003-11-20 US disclosed
US-6586368-B1 Benzofuran derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-07-01 US disclosed
EP-1225213-A1 LUBRICATING OIL FOR REFRIGERATOR, HYDRAULIC FLUID COMPOSITION FOR REFRIGERATOR AND METHOD FOR LUBRICATION OF REFRIGERATOR NEW JAPAN CHEMICAL CO.,LTD. (JP) 2002-07-24 EP disclosed
US-6410484-B1 ACTIVE MATERIAL; CONTROLLING WEEDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-06-25 US disclosed
CN-1344585-A Method for resisting carbon monoxide poisoning of noble metal catalyst CHINESE PETROCHEMICAL CO LTD (CN) 2002-04-17 CN disclosed
US-6339155-B1 Process for producing 3-phenyluracil compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-15 US disclosed
EP-1112268-A1 CONDENSED HETEROCYCLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2001-07-04 EP disclosed
EP-1101761-A2 Process for producing 3-phenyluracil compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-05-23 EP disclosed
EP-1095935-A1 6-Hydroxy-5,6-dihydrouracils as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-05-02 EP disclosed
CN-1260050-A Polymeric optical articles POSTON OPTICAL FIBER INC (US) 2000-07-12 CN disclosed
WO-2000015633-A1 CONDENSED HETEROCYLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-03-23 WO disclosed
EP-0285786-B1 METHOD OF PRODUCING ALCOHOLS Japan Tobacco Inc. (JP) 1993-05-05 EP disclosed
US-4880937-A REDUCING A CARBOXYLIC ACID OR ESTER, CATALYST JAPAN TOBACCO, INC. (JP) 1989-11-14 US disclosed
EP-0285786-A2 Method of producing alcohols Japan Tobacco Inc. (JP) 1988-10-12 EP disclosed
US-4374055-A ODORS, PERFUMES INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1983-02-15 US disclosed
US-4359395-A Process for enhancing the organoleptic properties of perfumed articles using alkyl esters of 1-alkanolyl cycloalkanols INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1982-11-16 US disclosed
US-4359395-A Process for enhancing the organoleptic properties of perfumed articles using alkyl esters of 1-alkanolyl cycloalkanols INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1982-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160062233-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN XDH, HAX1, MLX CYP19A1 328/4885EPHX1 1816/4885NAAA 1740/4885
US-20130172187-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS CTRC, ACE, DDT CYP19A1 2740/4885EPHX1 3677/4885NAAA 13/4885
US-20160353739-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS CTRC, ACE, DDT CYP19A1 2740/4885EPHX1 3677/4885NAAA 13/4885
US-20130123225-A1 INHIBITION OF BACTERIAL BIOFILMS WITH ARYL CARBAMATES PGLS, BLVRB, AADAC CYP19A1 3921/4885EPHX1 2418/4885NAAA 11/4885
US-20230382940-A1 ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME EIF2AK2, MAVS, ZC3HAV1 CYP19A1 4401/4885EPHX1 2624/4885NAAA 614/4885
US-11459315-B2 Modulators of methyl modifying enzymes, compositions and uses thereof TPMT, TET1, TET2 CYP19A1 213/4885EPHX1 726/4885NAAA 716/4885
US-20220274909-A1 METHOD FOR PRODUCING ALPHA-ACYLOXYCARBOXYLIC ACID ESTER ACACA, PCCA, APEH CYP19A1 153/4885EPHX1 799/4885NAAA 121/4885
US-20190055190-A1 PEPTIDE NUCLEIC ACID (PNA) MONOMERS WITH AN ORTHOGONALLY PROTECTED ESTER MOIETY AND NOVEL INTERMEDIATES AND METHODS RELATED THERETO TARBP1, TIA1, SSB CYP19A1 4375/4885EPHX1 2751/4885NAAA 83/4885
US-20130190344-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE HTR3B, HTR4, HTR2C CYP19A1 3876/4885EPHX1 393/4885NAAA 800/4885
US-20110245272-A1 PYRIDO[4,3-B]INDOLES AND METHODS OF USE HTR3B, HTR4, HTR2C CYP19A1 3876/4885EPHX1 393/4885NAAA 800/4885
US-12378181-B2 Method for producing alpha-acyloxycarboxylic acid ester ACACA, PCCA, APEH CYP19A1 153/4885EPHX1 799/4885NAAA 121/4885
US-20080125444-A1 ACYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS CPN1, HPN, HCCS CYP19A1 462/4885EPHX1 410/4885NAAA 753/4885
US-20190023666-A1 HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS ADORA2A, ADORA3, ADORA1 CYP19A1 4147/4885EPHX1 2260/4885NAAA 1995/4885
US-20110237817-A1 PROCESS FOR THE PREPARATION OF ACYLATED SECONDARY ALCOHOL ALKOXYLATES AND SECONDARY ALCOHOL ALKOXYLATES ADH1A, ADH1C, ADH5 CYP19A1 1012/4885EPHX1 2717/4885NAAA 671/4885
US-20130183269-A1 Hepatitis C Virus Inhibitors HAVCR2, MAVS, EIF2AK2 CYP19A1 4759/4885EPHX1 4506/4885NAAA 3321/4885
US-20150320875-A1 Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives PHPT1, SI, CA6 CYP19A1 1422/4885EPHX1 2276/4885NAAA 4/4885
US-11407732-B1 Tricyclic degraders of Ikaros and Aiolos CRBN, IKZF1, IKZF3 CYP19A1 2084/4885EPHX1 4053/4885NAAA 3225/4885
US-20150315146-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYLETHYNYL)-BICYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS AAK1, SYMPK, CBR1 CYP19A1 1270/4885EPHX1 1383/4885NAAA 901/4885
US-20090012324-A1 Process for Production of Carboxylic Acid Ester or Ether Compound TECR, CA14, ACSL4 CYP19A1 876/4885EPHX1 1264/4885NAAA 62/4885
US-11028058-B2 Heterocyclic compounds as adenosine antagonists ADORA2A, ADORA3, ADORA1 CYP19A1 4147/4885EPHX1 2260/4885NAAA 1995/4885
US-20090232868-A1 Nitric Oxide Releasing Polymer Composition NOS1, NOS3, NOS2 CYP19A1 312/4885EPHX1 2405/4885NAAA 208/4885
US-10202378-B2 Therapeutic compounds and uses thereof TAF1, TAF1L, TAF1B CYP19A1 2810/4885EPHX1 2926/4885NAAA 4462/4885
US-10882832-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof GRIN2A, GRIN2C, GRIN3A CYP19A1 377/4885EPHX1 873/4885NAAA 1432/4885
US-20150305334-A1 USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYL ETHYNYL)-CYCLOHEXANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS CBR1, CAT, NAT1 CYP19A1 968/4885EPHX1 1340/4885NAAA 774/4885
US-20080008681-A1 MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS PRSS1, SPINT2, TMPRSS4 CYP19A1 1225/4885EPHX1 778/4885NAAA 852/4885
US-20240067657-A1 AMIDO-SUBSTITUTED PYRIDYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPESVIRUSES TLR7, MALT1, PNPO CYP19A1 837/4885EPHX1 604/4885NAAA 838/4885
US-20170037075-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF PNP, NUDT1, NT5C2 CYP19A1 4075/4885EPHX1 1501/4885NAAA 322/4885
US-20090005387-A1 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS PRSS1, SPINT2, CTSC CYP19A1 1448/4885EPHX1 681/4885NAAA 559/4885
US-10968163-B2 Alpha-truxillic acid derivatives and pharmaceutical compositions thereof FABP1, FABP2, FABP4 CYP19A1 2672/4885EPHX1 4468/4885NAAA 1964/4885
US-20200181102-A1 BICYCLIC HETEROARYL DERIVATIVES AND PREPARATION AND USES THEREOF GRIN2A, GRIN2C, GRIN3A CYP19A1 377/4885EPHX1 873/4885NAAA 1432/4885
US-20170196848-A1 Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives PHPT1, SI, CA6 CYP19A1 1422/4885EPHX1 2276/4885NAAA 4/4885
US-10450301-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof BAD, AIFM1, BCL2 CYP19A1 3206/4885EPHX1 2281/4885NAAA 4101/4885
US-20070299078-A1 Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors PRSS1, SPINT2, CTSC CYP19A1 1448/4885EPHX1 681/4885NAAA 559/4885
US-10640476-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof GRIN2A, GRIN2C, GRIN3A CYP19A1 377/4885EPHX1 873/4885NAAA 1432/4885
US-20090202485-A1 HETEROARYL-CONTAINING TRIPEPTIDE HCV SERINE PROTEASE INHIBITORS PRSS1, CTSC, SPINT2 CYP19A1 1990/4885EPHX1 1086/4885NAAA 768/4885
US-20230040586-A1 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF TYMP, PNP, DUT CYP19A1 4201/4885EPHX1 1188/4885NAAA 766/4885
US-11739047-B2 Alpha-truxillic acid derivatives and pharmaceutical compositions thereof FABP1, FABP2, FABP4 CYP19A1 2842/4885EPHX1 4438/4885NAAA 2126/4885
US-20150327552-A1 USE OF ARYL CARBAMATES IN AGRICULTURE AND OTHER PLANT-RELATED AREAS CTRC, ACE, DDT CYP19A1 2740/4885EPHX1 3677/4885NAAA 13/4885
US-20160199355-A1 HEPATITIS C VIRUS INHIBITORS HAVCR2, MAVS, EIF2AK2 CYP19A1 4759/4885EPHX1 4506/4885NAAA 3321/4885
US-20170002037-A1 CYCLIC NUCLEOTIDE ANALOGS NT5C2, NTPCR, PNP CYP19A1 2454/4885EPHX1 739/4885NAAA 516/4885
US-11639337-B2 Bicyclic heteroaryl derivatives and preparation and uses thereof GRIN2A, GRIN2C, GRIN3A CYP19A1 377/4885EPHX1 873/4885NAAA 1432/4885
US-20150023913-A1 Hepatitis C Virus Inhibitors HAVCR2, MAVS, EIF2AK2 CYP19A1 4759/4885EPHX1 4506/4885NAAA 3321/4885
US-20150297568-A1 Hepatitis C Virus Inhibitors HAVCR2, MAVS, EIF2AK2 CYP19A1 4759/4885EPHX1 4506/4885NAAA 3321/4885
US-20180155384-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF PNP, NT5C3B, NT5C2 CYP19A1 4849/4885EPHX1 1225/4885NAAA 263/4885
US-20130245000-A1 BICYCLIC GPR119 MODULATORS GPR119, GPR180, GPBAR1 CYP19A1 444/4885EPHX1 1041/4885NAAA 2928/4885
US-20150038451-A1 SUBSTITUTED NUCLEOTIDE ANALOGS PNP, NUDT1, TYMP CYP19A1 4058/4885EPHX1 1477/4885NAAA 527/4885
US-20080032936-A1 Quinoxalinyl tripeptide hepatitis C virus inhibitors VIP, CTSC, PREP CYP19A1 1852/4885EPHX1 793/4885NAAA 484/4885
US-20030216258-A1 Condensed heterocylic compounds and herbicides containing them as active ingredients CBR3, CBR1, HAAO CYP19A1 951/4885EPHX1 236/4885NAAA 367/4885
US-20160158200-A1 Combinations of Hepatitis C Virus Inhibitors HAVCR2, EIF2AK2, MAVS CYP19A1 4777/4885EPHX1 4356/4885NAAA 3702/4885
US-20160052877-A1 SALT, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, AFF1, FRG1 CYP19A1 2813/4885EPHX1 4157/4885NAAA 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.